首页 > 市场调查报告书 > 製药

眼科药物

市场调查报告书

商品编码

1169121

眼部炎症治疗市场：按药物类别、配方、分销渠道、地区划分——规模、份额、展望、机会分析，2022-2030 年

Eye Inflammation Treatment Market, by Drug Class, by Dosage Form, by Distribution Channels,, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年11月18日 | 出版商:

Coherent Market Insights | 英文 260 Pages | 商品交期: 2-3个工作天内

价格

简介目录

眼睛炎症，也称为眼部炎症，是一种以眼睛的一个或多个区域肿胀为特征的疾病，可由轻微刺激到某些疾病引起。有。眼睛炎症按受影响的眼睛部分分类。分类包括巩膜炎、前葡萄膜炎、中间葡萄膜炎、后葡萄膜炎和全葡萄膜炎。全葡萄膜炎是影响整个眼球的炎症的总称。

眼睛发炎是由多种因素引起的，包括炎症性疾病、眼睛损伤、微生物感染如病毒、细菌和真菌感染，以及接触某些有害化学物质如强酸和杀虫剂。 .

市场动态

在预测期内，自身免疫性疾病患病率上升预计也将促进全球眼部炎症治疗市场的增长。例如，根据美国国家多发性硬化症协会于 2019 年 2 月在《神经病学》杂誌上发表的一项研究，2017 年美国有近 100 万成年人患有多发性硬化症。多发性硬化症是一种在炎症和视神经炎的情况下对视神经造成损害的疾病。视神经炎是多发性硬化症的早期症状。视神经炎会导致一隻眼睛出现眼痛和视力丧失等症状。类固醇被用作抑制视神经炎症的药物，有望带动全球眼部炎症市场。

此外，在预测期内，眼病的先进疗法有望推动全球眼部炎症疗法市场的增长。例如，根据美国眼科学会 2021 年 11 月 4 日发布的数据，新的干眼症治疗方法可能比现有的更有效。眼病的现代治疗方法包括改变生活方式、喷鼻剂、鼻塞、消炎药、深层冲洗装置和专用隐形眼镜。美国食品和药物管理局目前批准的干眼症药物有 Tirubaya、Restasis、Seaca、Cidra 和 Iceuvis。

这项研究的主要特点

本报告对全球眼部炎症治疗市场进行了深入分析，提供了以 2021 年为基准年的预测期 (2022-2030) 的市场规模和復合年增长率 (CAGR%)。我是这里。
它揭示了不同细分市场的潜在收入机会，并描述了该市场具有吸引力的投资建议矩阵。
它还提供关键见解，例如市场驱动因素、制约因素、机会、新产品发布或批准、区域前景以及主要参与者采用的竞争战略。
根据公司概况、业绩、产品组合、地域分布、分销策略、主要发展和策略以及未来计划等参数，对全球眼部炎症治疗药物市场的主要参与者进行了概况分析。
本研究涵盖的主要公司包括 GSK plc.、Alcon Laboratories Inc.、Merck & Co. Inc.、Alimera Sciences, Inc.、AbbVie Inc.、Teva Pharmaceutical Industries Ltd.、Akron Pharma Inc.、Intas Pharmaceuticals Ltd.、Amgen Inc.、Sanofi S.A.、Johnson & Johnson Services Inc.、Pfizer Inc.、Macleods Pharmaceuticals Ltd.、Mylan N.V.、Bausch Health Companies Inc.
这份报告中的见解将使企业营销人员和高管能够就未来的产品发布、技术升级、市场扩张和营销策略做出明智的决策。我猜。
《全球眼部炎症治疗药物市场》报告面向该行业的各种利益相关者，包括投资者、供应商、製造商、分销商、新进入者和金融分析师。
利益相关者可以通过用于分析全球眼部炎症治疗市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

调查目的
先决条件
缩写说明

第 2 章市场概述

报告内容
- 市场定义和范围
执行摘要
- 市场细分：按药物类别
- 市场细分：按剂型
- 市场细分：按分销渠道
- 按地区划分的市场细分
连贯机会图 (COM)

第3章市场动态、规律及趋势分析

市场动态
- 司机
- 约束因素
- 市场机会
影响分析
监管场景
害虫分析
最近的产品发布/批准
流行病学
併购

第 4 章全球眼部炎症药物市场 - 冠状病毒 (COVID-19) 大流行的影响

对供应链的影响
对研发的影响
政府举措

第 5 章全球眼部炎症药物市场：按药物类别，2017-2030

单克隆抗体
抗生素
皮质类固醇
抗病毒剂
抗真菌剂
其他（止痛药等）

第 6 章全球眼部炎症药物市场：按配方分类，2017-2030

眼药水
药丸
胶囊
其他（眼药膏等）

第 7 章全球眼部炎症治疗市场：按分销渠道，2017-2030

医院药房
零售药房
在线药店

第 8 章全球眼部炎症药物市场，按地区划分，2017-2030

北美
美国
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲地区
欧洲
德国
英国
法国
意大利
西班牙
俄罗斯
其他欧洲地区
亚太地区
中国
印度
日本
澳大利亚
韩国
东盟
其他亚太地区
中东
海湾合作委员会
以色列
其他中东地区
非洲
南非
中非
北非

第9章竞争格局

公司简介
- GSK plc.
- Alcon Laboratories Inc.
- Merck & Co. Inc.
- Alimera Sciences, Inc.,
- AbbVie Inc
- Teva Pharmaceutical Industries Ltd.
- Akron Pharma Inc
- Intas Pharmaceuticals Ltd
- Amgen Inc.
- Sanofi S.A.
- Johnson & Johnson Services Inc.
- Pfizer Inc.
- Macleods Pharmaceuticals Ltd.
- Mylan N.V.
- Bausch Health Companies Inc.

第 10 章

参考资料
调查方法

简介目录

Product Code: CMI5362

Eye inflammation, also known as ocular inflammation, is a disorder marked by the swelling of one or more eye regions and can be brought on by a number of different things, from minor irritation to specific illnesses. Eye Inflammation is classified according to the part of the eye that has been affected. Scleritis, Anterior Uveitis, Intermediate Uveitis, Posterior Uveitis, and Panuveitis are the different classifications. Panuveitis is a general word for an inflammation that affects the entire eye.

Eye inflammation is caused by various factors such as inflammatory diseases, injuries in the eye, microbial infections such as viral, bacterial, and fungal infection or exposure to certain toxic chemicals such as strong acids or pesticides.

Market Dynamics

Increasing prevalence of autoimmune disorders is also expected to benefit in growth of the global eye inflammation treatment market, over the forecast period. For instance, according to a study published in February 2019 by National Multiple Sclerosis Society, in the journal Neurology, in 2017, nearly 1 million adults were living with multiple sclerosis in the U.S. Multiple sclerosis is a disease that reasons inflammation and damage to the optic nerve that cases optic neuritis. Optic neuritis as an early sign of multiple sclerosis. Optic neuritis causes pain in eye, vision loss in one eye, etc. Steroid are used as a medication to reduce inflammation in the optic nerve, which is expected to drive the global eye inflammation market.

Moreover, advanced treatment of eye disease is expected to propel the growth of global eye inflammation treatment market, over the forecast period. For instance, according to data published on November 04, 2021, by American Academy of Ophthalmology, new dry eye treatments may be more effective than existing ones. Modern treatments for eye disease include lifestyle changes, a nasal spray, punctual plugs, anti-inflammatory medications, deep-cleaning devices, and specialized contact lenses. Currently available medications for the treatment of dry eye disease, approved by the U.S. Food and Drug Administration are Tyrvaya, Restasis, Cequa, Xiidra and Eysuvis.

Key features of the study:

This report provides an in-depth analysis of the global eye inflammation treatment market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global eye inflammation treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include GSK plc., Alcon Laboratories Inc., Merck & Co. Inc., Alimera Sciences, Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Akron Pharma Inc., Intas Pharmaceuticals Ltd., Amgen Inc., Sanofi S.A., Johnson & Johnson Services Inc., Pfizer Inc., Macleods Pharmaceuticals Ltd., Mylan N.V., Bausch Health Companies Inc.
Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global eye inflammation treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global eye inflammation treatment market

Detailed Segmentation:

Global Eye Inflammation Treatment Market, By Drug Class:
- Monoclonal Antibodies
- Antibiotics
- Corticosteroids
- Antivirals
- Antifungal
- Others (Analgesics, etc.)
Global Eye Inflammation Treatment Market, By Dosage Form:
- Eye Drops
- Tablets
- Capsules
- Others (Ophthalmic Ointments, etc.)
Global Eye Inflammation Treatment Market, By Distribution Channels:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Eye Inflammation Treatment Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
  - By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Region:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Novartis AG *
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Alcon Laboratories Inc.
- Merck & Co. Inc.
- Alimera Sciences, Inc.,
- AbbVie Inc
- Teva Pharmaceutical Industries Ltd.
- Akron Pharma Inc
- Intas Pharmaceuticals Ltd
- Amgen Inc.
- Sanofi S.A.
- Johnson & Johnson Services Inc.
- Pfizer Inc.
- Macleods Pharmaceuticals Ltd.
- Mylan N.V.
- Bausch Health Companies Inc.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Dosage Form
- Market Snippet, By Distribution Channels
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Regulatory Scenario
PEST Analysis
Recent Product Launch/Approval
Epidemiology
Mergers and Acquisitions

4. Global Eye Inflammation Treatment Market - Impact of Coronavirus (Covid-19) Pandemic

Impact on Supply Chain
Impact on Research and Development
Government Initiatives

5. Global Eye Inflammation Treatment Market, By Drug Class, 2017-2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Antivirals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Antifungal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Others (Analgesics, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

6. Global Eye Inflammation Treatment Market, By Dosage Form, 2017 - 2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Eye Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Others (Ophthalmic Ointments, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

7. Global Eye Inflammation Treatment Market, By Distribution Channels, 2017 - 2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

8. Global Eye Inflammation Treatment Market, By Region, 2017 - 2030 (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2030
- Regional Trends
North America
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Dosage Form, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channels, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
U.S.
Canada
Latin America
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Dosage Form, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channels, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Dosage Form, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channels, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Dosage Form, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channels, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Dosage Form, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channels, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Dosage Form, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channels, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
South Africa
Central Africa
North Africa